To examine the downstream mechanism accounting for how ASPP2 deficiency is able to cause a reduction in tumor growth in pancreatic cancer, RNA-Seq was performed, and the differentially expressed genes in control and ASPP2-depleted S2.013 cells were compared. This evidence concerns the gene TP53BP2 and familial pancreatic carcinoma.